Skip to main content
Skip to main content
MenuSearch & Directory

Health Law Examine

A Look at the Health Law Horizon

Health Law Examine brings the Jesuit tradition of a daily examen to health law. The blog provides a space to review the health law “day," critically reflecting on what is missing from the health law conversation, and anticipate what is on the health law horizon.

Recent Posts

Grace Peterson

Grace Peterson, now the Appellate Law Clerk to the Chief Justice of the Supreme Court of the U.S. Virgin Islands, attributes the confidence needed to start her career “in the middle of the ocean” to her education at SLU LAW.  

Professor Michael Carrier

Pharmaceutical antitrust presents unique challenges to antitrust law. Market forces are different for pharmaceuticals than they are for most other products: The party who chooses the product is different from the party who pays for and consumes the product, and this situation is ripe for anticompetitive behavior. SLU LAW student Mary Quandt recaps Distinguished Speaker Professor Michael Carrier’s recent talk on the challenges of pharmaceutical antitrust.

Professor Mary Crossley

At the intersection of Blackness and disability is a population of especially vulnerable people, as racism and ableism mutually reinforce each other. Disability is more prevalent among Black people than white people, and Black people are more likely to develop a disability at a younger age — a direct result of structural racism. SLU LAW student Mary Quandt recaps Distinguished Speaker Professor Mary Crossley’s recent talk on her new book, Embodied Injustice: Race, Disability, and Health.

Ana Santos Rutschman book

Vaccination is a world-changing technology whose development and distribution are governed by laws controlling pharmaceuticals, intellectual property, marketing, patents, and medicine. SLU LAW student Mary Quandt recaps Distinguished Speaker Professor Ana Santos Rutschman’s recent talk on how future vaccine scholarship and policymaking will hopefully move towards regulating vaccines not just for their transactional benefits, but also to increase accessibility and health equity.